3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
52
Breast Neoplasms
24
Lung Neoplasms
21
Triple Negative Breast Neoplasms
16
Neoplasm Metastasis
16
Pancreatic Neoplasms
15
Neoplasms
15
Colorectal Neoplasms
14
Stomach Neoplasms
13
Head and Neck Neoplasms
12
Esophageal Neoplasms
12
Esophageal Squamous Cell Carcinoma
11
Uterine Cervical Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Small Cell Lung Carcinoma
9
Rectal Neoplasms
8
Ovarian Neoplasms
8
Leukemia, Myeloid, Acute
8
Recurrence
7
Nasopharyngeal Carcinoma
7
Glioblastoma
5
Fallopian Tube Neoplasms
5
Cholangiocarcinoma
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Mouth Neoplasms
4
Lymphoma
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Interventions
Bupivacaine
4
Saline Solution
3
Ketamine
3
Transcutaneous Electric Nerve Stimulation
2
Ropivacaine
2
Radiofrequency Ablation
2
Magnesium Sulfate
2
Ketorolac
2
Dexmedetomidine
2
Control Groups
2
Anesthesia, Local
2
Acupuncture Therapy
2
Acetaminophen
2
engage 8200
1
Yoga
1
Varenicline
1
Transdermal Patch
1
Therapeutics
1
Telemedicine
1
Surgical Instruments
1
STAMP-I protocol
1
Radiosurgery
1
Psilocybin
1
Palliative Care
1
Oxycodone
1
Music Therapy
1
Morphine
1
Methods
1
Levobupivacaine
1
Ketoprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Drug Therapy
×
1 year
×
Clear all
NCT07152938
2025-09-15
AVR-CHEMO
Arab American University (Palestine)
Phase NA
Completed
150 enrolled